Search

Your search keyword '"Almenar Bonet L"' showing total 386 results

Search Constraints

Start Over You searched for: Author "Almenar Bonet L" Remove constraint Author: "Almenar Bonet L"
386 results on '"Almenar Bonet L"'

Search Results

3. Molecular Alterations of Nucleocytoplasmic Transport in Patients on the Heart Transplantation Waiting List and Its Correlation With the Severity and Etiology of Heart Failure

4. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

5. Validation of miR-181A-5p as a biomarker of acute rejection after heart transplantation. Multicenter study

8. Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry

13. Donor-Transmitted Coronary Artery Disease in Heart Transplantation: Prevalence and Characteristics in the Real World. Results from the Multicentric Donor Coronary Artery Disease (DONOR-CAD) Study

15. Changes over the years in the indication for heart-lung transplantation in Spain

23. Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction

24. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

25. Validation of the patient assessment of chronic illness care (PACIC) short form scale in heart transplant recipients: the international cross-sectional bright study

26. The Prognosis of Noncutaneous, Nonlymphomatous Malignancy After Heart Transplantation: Data From the Spanish Post-Heart Transplant Tumour Registry

34. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

35. The falling incidence of hematologic cancer after heart transplantation

36. Impact of intrapatient blood level variability of calcineurin inhibitors on heart transplant outcomes

38. Plasma Levels of SERCA2a as a Noninvasive Biomarker of Primary Graft Dysfunction After Heart Transplantation

40. Malignancy following Heart Transplantation: Differences in Incidence and Prognosis between Sexes

41. Administration of Subcutaneous Furosemide in Elastomeric Pump vs. Oral Solution for the Treatment of Diuretic Refractory Congestion

43. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

44. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

45. Rivaroxaban for thromboprophylaxis after hospitalization for medical illness

46. Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

50. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

Catalog

Books, media, physical & digital resources